Sejong Medical Co., Ltd.

KOSDAQ:A258830 Stock Report

Market Cap: ₩23.0b

Sejong Medical Past Earnings Performance

Past criteria checks 0/6

Sejong Medical's earnings have been declining at an average annual rate of -94%, while the Medical Equipment industry saw earnings growing at 16.2% annually. Revenues have been growing at an average rate of 3% per year.

Key information

-94.0%

Earnings growth rate

-88.8%

EPS growth rate

Medical Equipment Industry Growth22.7%
Revenue growth rate3.0%
Return on equityn/a
Net Margin-374.9%
Last Earnings Update31 Mar 2024

Recent past performance updates

Recent updates

Sejong Medical (KOSDAQ:258830) Might Be Having Difficulty Using Its Capital Effectively

Mar 24
Sejong Medical (KOSDAQ:258830) Might Be Having Difficulty Using Its Capital Effectively

Update: Sejong Medical (KOSDAQ:258830) Stock Gained 53% In The Last Year

Mar 02
Update: Sejong Medical (KOSDAQ:258830) Stock Gained 53% In The Last Year

Does The Market Have A Low Tolerance For Sejong Medical Co., Ltd.'s (KOSDAQ:258830) Mixed Fundamentals?

Feb 11
Does The Market Have A Low Tolerance For Sejong Medical Co., Ltd.'s (KOSDAQ:258830) Mixed Fundamentals?

We're Not Counting On Sejong Medical (KOSDAQ:258830) To Sustain Its Statutory Profitability

Jan 27
We're Not Counting On Sejong Medical (KOSDAQ:258830) To Sustain Its Statutory Profitability

Is Sejong Medical Co., Ltd. (KOSDAQ:258830) A Smart Choice For Dividend Investors?

Jan 12
Is Sejong Medical Co., Ltd. (KOSDAQ:258830) A Smart Choice For Dividend Investors?

Income Investors Should Know That Sejong Medical Co., Ltd. (KOSDAQ:258830) Goes Ex-Dividend Soon

Dec 25
Income Investors Should Know That Sejong Medical Co., Ltd. (KOSDAQ:258830) Goes Ex-Dividend Soon

Should We Be Excited About The Trends Of Returns At Sejong Medical (KOSDAQ:258830)?

Dec 23
Should We Be Excited About The Trends Of Returns At Sejong Medical (KOSDAQ:258830)?

These 4 Measures Indicate That Sejong Medical (KOSDAQ:258830) Is Using Debt Reasonably Well

Dec 08
These 4 Measures Indicate That Sejong Medical (KOSDAQ:258830) Is Using Debt Reasonably Well

The Sejong Medical (KOSDAQ:258830) Share Price Has Gained 42% And Shareholders Are Hoping For More

Nov 19
The Sejong Medical (KOSDAQ:258830) Share Price Has Gained 42% And Shareholders Are Hoping For More

Revenue & Expenses Breakdown

How Sejong Medical makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

KOSDAQ:A258830 Revenue, expenses and earnings (KRW Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Mar 2419,101-71,6058,6391,175
31 Dec 2317,992-23,0877,817880
31 Dec 2216,083-91,3666,9831,473
30 Sep 2216,931-5,4119,4121,294
30 Jun 2213,361-5,3756,882771
31 Mar 2217,759-6,1118,7051,275
31 Dec 2118,021-5,1928,1451,528
30 Sep 2117,703-1,7626,1832,103
30 Jun 2117,079-9856,0572,174
31 Mar 2115,881-645,4302,232
31 Dec 2015,0984705,2972,127
30 Sep 2015,4651,6825,3691,693
30 Jun 2015,2382,6684,6131,435
31 Mar 2015,8293,1734,5701,166
31 Dec 1916,2303,4644,5421,057
30 Sep 1915,9243,6364,3711,295
30 Jun 1915,9273,9424,2971,246
31 Mar 1915,3093,6954,3871,228
31 Dec 1814,8333,7874,1131,202
30 Sep 1813,6222,3154,3421,200
30 Jun 1814,1022,5164,3671,140
31 Mar 1814,4733,1673,9621,063
31 Dec 1714,5503,2143,912987
31 Dec 1612,7733,1693,075916
31 Dec 1511,9571,5502,9961,006

Quality Earnings: A258830 is currently unprofitable.

Growing Profit Margin: A258830 is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: A258830 is unprofitable, and losses have increased over the past 5 years at a rate of 94% per year.

Accelerating Growth: Unable to compare A258830's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: A258830 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (4.1%).


Return on Equity

High ROE: A258830's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.


Return on Assets


Return on Capital Employed


Discover strong past performing companies